tiprankstipranks
Trending News
More News >
Maze Therapeutics, Inc. (MAZE)
NASDAQ:MAZE
US Market
Advertisement

Maze Therapeutics, Inc. (MAZE) Technical Analysis

Compare
25 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
8Bullish
0Neutral
2Bearish
Maze Therapeutics, Inc.’s (MAZE) Moving Averages Convergence Divergence (MACD) indicator is 1.33, suggesting Maze Therapeutics, Inc. is a Sell.
Maze Therapeutics, Inc.’s (MAZE) 20-Day exponential moving average is 15.40, while Maze Therapeutics, Inc.’s (MAZE) share price is $16.45, making it a Buy.
Maze Therapeutics, Inc.’s (MAZE) 50-Day exponential moving average is 13.59, while Maze Therapeutics, Inc.’s (MAZE) share price is $16.45, making it a Buy.

Maze Therapeutics, Inc. (MAZE) Pivot Points

Jul 26, 2025, 10:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.28
14.69
15.57
16.99
17.87
19.28
20.16
Fibonacci
14.69
15.57
16.11
16.99
17.86
18.40
19.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Maze Therapeutics, Inc. (MAZE) Moving Averages

Jul 26, 2025, 10:08 PM
Period
Simple
Exponential
MA5
16.90Sell
16.84Sell
MA10
16.74Buy
16.44Buy
MA20
14.99Buy
15.40Buy
MA50
12.95Buy
13.59Buy
MA100
11.51Buy
12.37Buy
MA200
Maze Therapeutics, Inc.’s (MAZE) 10-Day exponential moving average is 16.44, while Maze Therapeutics, Inc.’s (MAZE) share price is $16.45, making it a Buy.
Maze Therapeutics, Inc.’s (MAZE) 100-Day exponential moving average is 12.37, while Maze Therapeutics, Inc.’s (MAZE) share price is $16.45, making it a Buy.
Maze Therapeutics, Inc.’s (MAZE) stock price is $16.45 and Maze Therapeutics, Inc.’s (MAZE) 50-day simple moving average is 12.95, creating a Buy signal.
Maze Therapeutics, Inc.’s (MAZE) stock price is $16.45 and Maze Therapeutics, Inc.’s (MAZE) 100-day simple moving average is 11.51, creating a Buy signal.

Maze Therapeutics, Inc. (MAZE) Technical Indicators

Jul 26, 2025, 10:08 PM
Name
Value
Implied Action
RSI (14)
61.70
Neutral
STOCH (9,6)
52.08
Neutral
STOCHRSI (14)
70.37
Neutral
MACD (12,26)
1.33
Sell
ADX (14)
28.07
Neutral
Williams %R
-35.11
Buy
CCI (14)
63.48
Neutral
ATR (14)
1.52
-
Ultimate Oscillator
50.44
Neutral
ROC
38.78
Buy
Maze Therapeutics, Inc.’s (MAZE) Relative Strength Index (RSI) is 61.70, creating a Neutral signal.
Maze Therapeutics, Inc.’s (MAZE) Trend Strength Indicator (ADX) is 28.07, creating a Neutral signal.
Maze Therapeutics, Inc.’s (MAZE) Commodity Channel Index (CCI) is 63.48, creating a Neutral signal.
Maze Therapeutics, Inc.’s (MAZE) Price Rate of Change (ROC) is 38.78, creating a Buy signal.

FAQ

Is MAZE a Buy, Hold, or Sell?
Based on MAZE’s technical indicators, MAZE is a Buy.
    What is MAZE’s RSI (14)?
    MAZE’s RSI (14) is 61.70, which suggests MAZE is a Neutral.
      What is MAZE’s MACD?
      MAZE’s MACD is 1.33, which suggests MAZE is a Sell.
        What is MAZE’s 5-day moving average?
        MAZE’s 5-day moving average is 16.90, which suggests MAZE is a Sell.
          What is MAZE’s 20-day moving average?
          MAZE 20-day moving average is 14.99, which suggests MAZE is a Buy.
            What is MAZE’s 50-day moving average?
            MAZE’s 50-day moving average is 12.95, which suggests MAZE is a Buy.
              What is MAZE’s 200-day moving average?
              Currently, no data Available
              What is MAZE’s Williams % R (14)?
              MAZE’s Williams % R (14) is -35.11, which suggests MAZE is a Buy.
                What is MAZE’s CCI (14)?
                MAZE’s CCI (14) is 63.48, which suggests MAZE is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis